Transpara 1.7.2

Radiological Computer Assisted Detection/diagnosis Software For Lesions Suspicious For Cancer

ScreenPoint Medical B.V.

The following data is part of a premarket notification filed by Screenpoint Medical B.v. with the FDA for Transpara 1.7.2.

Pre-market Notification Details

Device IDK221347
510k NumberK221347
Device Name:Transpara 1.7.2
ClassificationRadiological Computer Assisted Detection/diagnosis Software For Lesions Suspicious For Cancer
Applicant ScreenPoint Medical B.V. Mercator II, 7th Floor, Teornooiveld 300 Nijmegen,  NL 6525EC
ContactRobin Barwegen
CorrespondentRobin Barwegen
ScreenPoint Medical B.V. Mercator II, 7th Floor, Teornooiveld 300 Nijmegen,  NL 6525EC
Product CodeQDQ  
CFR Regulation Number892.2090 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2022-05-09
Decision Date2022-08-03

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
08720387058013 K221347 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.